文献速递瓣膜外科

机器人二尖瓣修复:十年经验与超声心动图随访

Robotic Mitral Valve Repair: A Decade of Experience With Echocardiographic Follow-up.
PubMed 文献 · Ann Thorac Surg · 2021-11-18

该研究回顾了2008至2019年单中心843例机器人二尖瓣修复患者,中位年龄58岁,男性591例(70.1%)。早期死亡3例(0.4%),早期再手术24例(2.8%)。超声随访显示左心室收缩及舒张末内径、左心房容积指数和肺动脉压力持续改善至术后2年,射血分数术后即刻下降后逐渐恢复至接近正常。10年生存率93%,免于再手术率92.6%。

要点

  • 机器人二尖瓣修复术后2年内左心室内径、左心房容积指数及肺动脉压力持续改善。
  • 术后射血分数即刻下降,但2年内逐渐恢复至接近正常。
  • 10年生存率93%,免于再手术率92.6%,与标准开放修复相当。

核心结论

  • 机器人二尖瓣修复安全有效,长期结果优异,超声心动图数据显示心脏 chamber 大小早期改善且术后心功能维持。
  • 极低的死亡率和免于再手术率与标准开放修复相当。

研究设计与样本

  • 单中心、三级机构11年回顾性队列,纳入2008年至2019年843例机器人二尖瓣修复患者。
  • 采用重复测量广义最小二乘(GLS)模型评估超声心动图随时间的变化。

主要发现

  • 中位年龄58岁(四分位距50.8-65.5岁),男性591例(70.1%)。
  • 二尖瓣反流机制:后叶脱垂479例(56.8%),双叶脱垂325例(38.6%),前叶脱垂36例(4.3%)。
  • 早期死亡3例(0.4%),早期再手术24例(2.8%)。
  • 超声随访显示左心室收缩及舒张末内径、左心房容积指数和肺动脉压力持续改善至术后2年。
  • 射血分数术后即刻下降,随后2年内逐渐改善至接近正常。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical approaches for mitral valve (MV) disease have evolved with the aim of developing minimally invasive techniques. Although the safety of robotic procedures has been documented, there are limited data on long-term echocardiographic follow-up. This review demonstrates outcomes of 11 years of robotic MV repair at a single, tertiary institution. METHODS: From 2008 to 2019, 843 patients underwent robotic MV repair at Mayo Clinic in Rochester, Minnesota. Repeated measures generalized least squares (GLS) modeling was used to assess the echocardiographic changes over time. RESULTS: The median age was 58 years (interquartile range, 50.8, 65.5 years), and 591 were male (70.1%). The mechanism of mitral regurgitation was posterior leaflet prolapse in 479 (56.8%) patients, bileaflet prolapse in 325 (38.6%), and anterior leaflet prolapse in 36 (4.3%). There were 3 early deaths (0.4%) and 24 early reoperations (2.8%). Echocardiographic follow-up demonstrated left ventricular end-systolic and end-diastolic dimensions, left atrial volume index, and pulmonary pressure all continuously improved up to 2 years postoperatively. Ejection fraction immediately declined postoperatively but then gradually improved to near normal over 2 years. Survival and freedom from reoperation at 10 years were 93% and 92.6%, respectively. When patients were surveyed after dismissal, 93.4% reported their activity level at or above their peers, and 93.3% reported no activity limitation from cardiac symptoms. CONCLUSIONS: Robotic MV repair is safe and effective with excellent long-term results, including echocardiographic data that demonstrated early improvement in cardiac chamber size and maintenance of postoperative cardiac function. Exceedingly low mortality rates and freedom from reoperation are comparable to those of the standard open repair.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Arghami A, Jahanian S, Daly RC, et al. Robotic Mitral Valve Repair: A Decade of Experience With Echocardiographic Follow-up. Ann Thorac Surg. 2021. PMID: 34800487. doi:10.1016/j.athoracsur.2021.08.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。